COMMUNIQUÉS West-GlobeNewswire

AXIM® Biotechnologies, Inc. Announces Attendance and Presentation by Chief Technology Officer Lekhram Changoer at Kannaway® “Believe” National Convention
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced the company’s [...]
Helping to Add Esophageal Adenocarcinoma to the List of Preventable Cancers
12/04/2019
- Early detection of Barrett’s esophagus and dysplasia with WATS 3D offers new solution to one of the most rapidly growing and fatal cancers in the United States - SUFFERN, N.Y., April 12, 2019 (GLOBE NEWSWIRE) -- CDx [...]
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio broadcast titled, “ Potential Blockbuster Gene Therapy Programs to Watch [...]
Wildflower Featured in CannabisNewsAudio Broadcast on Growing Acceptance, Soaring Sales in CBD Market
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Publication titled, “ Increasing Growth, Acceptance [...]
Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference
12/04/2019
TORONTO, April 12, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries ") a Latin American licensed producer of medicinal cannabis and cannabis- [...]
Blissco Signs Saskatchewan Distribution and Supply Agreement with National Cannabis Distribution
12/04/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, April 12, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
AMAG Pharmaceuticals Appoints New Members to Board of Directors
12/04/2019
WALTHAM, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the election of two new members to its Board of Directors—Anne Phillips, M.D., senior vice president, clinical [...]
Wave Life Sciences to Host Investor Conference Call to Discuss Suvodirsen DMD Clinical Data Being Presented at MDA Clinical and Scientific Conference
12/04/2019
Suvodirsen Phase 1 Safety and Tolerability Results Accepted for Oral Presentation Investor Conference Call and Webcast Scheduled for Tuesday, April 16 CAMBRIDGE, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Wave Life [...]
Rexahn Effects 1-for-12 Reverse Stock Split
12/04/2019
ROCKVILLE, MD, April 12, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]
OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial
12/04/2019
MIAMI, April 12, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today reported additional results from the per protocol patient population from the Phase 2 dose escalation trial of OPK-88003 to treat type 2 [...]
CymaBay Therapeutics Presents Positive Phase 2 Data for Seladelpar in Patients with Primary Biliary Cholangitis at the International Liver Congress™ 2019
12/04/2019
NEWARK, Calif., April 12, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and [...]
FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)
12/04/2019
TEL AVIV, Israel, April 12, 2019 (GLOBE NEWSWIRE) -- FameWave Ltd. a privately held biopharmaceutical company developing CM-24, which is being acquired by Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), today announced the [...]
Biogen Continues to Advance Innovation in SMA with New Data in Adults and Infants to Be Presented at MDA Clinical and Scientific Conference
12/04/2019
Adults with later-onset spinal muscular atrophy (SMA) who are not being treated show increased rates of hospital admissions, clinical interventions and mortality, indicating an unmet medical need Infants with pre- [...]
Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress™ 2019 (EASL)
12/04/2019
LEXINGTON, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]
Better Choice Company Signs Memorandum of Understanding with Nutrisur S.A. for Development Rights of CBD Infused Pet Supplements
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (OTCQB: BTTRD) (the “Company”) is pleased to announce that it has signed a memorandum of understanding (“MOU”) with Nutrisur S.A. (“ [...]
TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee
12/04/2019
Company to Host Investor Conference Call Today at 8:30 a.m. EDT / 5:30 a.m. PDT SAN DIEGO, April 12, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on [...]
Information on changes in the Management Boards of the subsidiaries of JSC Olainfarm and in authorization rights
12/04/2019
In addition to the previously published information on changes in the Management Board of JSC Olainfarm and of the recall of O. Grigorjevs, I. Krūkle, M. Raizbergs and V. Krušinskis from the position of a member of the [...]
Spring Bank Announces Positive Results from the Recently Completed Phase 2 Chronic Hepatitis B ACHIEVE Trial and Additional Inarigivir Studies
12/04/2019
Consistent reduction in HBV DNA demonstrated with higher inarigivir doses including in high viral burden HBeAg-positive patients 26% HBsAg responder population for all inarigivir doses showed mean HBsAg change of 0.8log [...]
Aleafia Health Applauds Commitment to Private Retail Expansion in Ontario Budget
12/04/2019
Company has Equity Stakes and Supply Agreements With Three Major Retail Partners Budget Announced Major Expansion of Cannabis Retail Licences in Canada’s Largest Province TORONTO, April 12, 2019 (GLOBE NEWSWIRE) -- [...]

Pages